On the other hand, CEBPA may also act as an oncogene in AML, since it was shown to inhibit both the intrinsic and extrinsic pathways of apoptosis by epigenetically activating the expression of two antiapoptotic genes, bcl2 and FLIP, respectively [28]. The gene discussed is BCL2; the disease is acute myeloid leukemia.